SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 26, 2024
Document Date
Apr 1, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Aquestive Therapeutics
Issuer
Aquestive Therapeutics, Inc.
Filer
JENKINS ABIGAIL L.
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds